Drug Type AAV based gene therapy |
Synonyms AAV-TT coHGSNAT gene therapy (Phoenix Nest) |
Target |
Action modulators |
Mechanism HGSNAT modulators(heparan-alpha-glucosaminide N-acetyltransferase modulators), Gene transference(Gene transference) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucopolysaccharidosis III | Preclinical | United States | 13 May 2025 |